Startseite Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children

  • Kimiya Karbasy , Danny C.C. Lin , Alexandra Stoianov , Man Khun Chan , Victoria Bevilacqua , Yunqi Chen und Khosrow Adeli EMAIL logo
Veröffentlicht/Copyright: 10. Oktober 2015
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The CALIPER program is a national research initiative aimed at closing the gaps in pediatric reference intervals. CALIPER previously reported reference intervals for endocrine and special chemistry markers on Abbott immunoassays. We now report new pediatric reference intervals for immunoassays on the Beckman Coulter Immunoassay Systems and assess platform-specific differences in reference values.

Methods: A total of 711 healthy children and adolescents from birth to <19 years of age were recruited from the community. Serum samples were collected for measurement of 29 biomarkers on the Beckman Coulter Immunoassay Systems. Statistically relevant age and/or gender-based partitions were determined, outliers removed, and reference intervals calculated in accordance with Clinical and Laboratory Standards Institute (CLSI) EP28-A3c guidelines.

Results: Complex profiles were observed for all 29 analytes, necessitating unique age and/or sex-specific partitions. Overall, changes in analyte concentrations observed over the course of development were similar to trends previously reported, and are consistent with biochemical and physiological changes that occur during childhood. Marked differences were observed for some assays including progesterone, luteinizing hormone and follicle-stimulating hormone where reference intervals were higher than those reported on Abbott immunoassays and parathyroid hormone where intervals were lower.

Conclusions: This study highlights the importance of determining reference intervals specific for each analytical platform. The CALIPER Pediatric Reference Interval database will enable accurate diagnosis and laboratory assessment of children monitored by Beckman Coulter Immunoassay Systems in health care institutions worldwide. These reference intervals must however be validated by individual labs for the local pediatric population as recommended by CLSI.


Corresponding author: Khosrow Adeli, Clinical Biochemistry, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8 Canada, E-mail: ; CALIPER program, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
aKimiya Karbasy and Danny C.C. Lin contributed equally to this study.

Acknowledgments

We thank all of the CALIPER participants and their families; this study would not have been possible without their participation. We also thank the CALIPER coordinators, and all of the CALIPER volunteers for their hard work in participant recruitment and sample collection. Lastly, we acknowledge Dr. Jack Zakowski for his critical review of the manuscript, and the Beckman Coulter staff for their sample analysis work.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: This study was supported by an operating grant from the CIHR (Canadian Institutes of Health Research) and Beckman Coulter, Inc.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ceriotti F. Establishing pediatric reference intervals: a challenging task. Clin Chem 2012;58:808–10.10.1373/clinchem.2012.183483Suche in Google Scholar PubMed

2. Savage WJ, Everett AD. Biomarkers in pediatrics: children as biomarker orphans. Proteomics Clin Appl 2010;4:915–21.10.1002/prca.201000062Suche in Google Scholar PubMed

3. Schnabl K, Chan MK, Adeli K. Pediatric reference intervals: critical gap analysis and establishment of a national initiative. Clin Biochem 2006;39:559–60.10.1016/j.clinbiochem.2006.03.009Suche in Google Scholar PubMed

4. Konforte D, Shea JL, Kyriakopoulou L, Colantonio D, Cohen AH, Shaw J, et al. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals. Clin Chem 2013;59:1215–27.10.1373/clinchem.2013.204123Suche in Google Scholar PubMed

5. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.10.1373/clinchem.2011.177741Suche in Google Scholar PubMed

6. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013;59:1393–405.10.1373/clinchem.2013.204222Suche in Google Scholar PubMed

7. Bevilacqua V, Chan MK, Chen Y, Armbruster D, Schodin B, Adeli K. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. Clin Chem 2014;60:1532–42.10.1373/clinchem.2014.229799Suche in Google Scholar PubMed

8. Estey MP, Cohen AH, Colantonio DA, Chan MK, Marvasti TB, Randell E, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013;46:1197–219.10.1016/j.clinbiochem.2013.04.001Suche in Google Scholar PubMed

9. CLSI. Defining, establishing and verifying reference intervals in the clinical laboraotory. Approved guideline, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.Suche in Google Scholar

10. Tukey JW. Exploratory data analysis. Boston, MA: Addison-Wesley, 1977.Suche in Google Scholar

11. Hubert M, Van der Veeken S. Outlier detection for skewed data. J Chemometrics 2008;22:235–46.10.1002/cem.1123Suche in Google Scholar

12. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265–70.10.1093/clinchem/36.2.265Suche in Google Scholar

13. Horn PS, Pesce AJ. Reference intervals: a user’s guide. Washington, DC: AACC Press, 2005.Suche in Google Scholar

14. Samuelson G, Lonnerdal B, Kempe B, Elverby JE, Bratteby LE. A follow-up study of serum ferritin and transferrin receptor concentrations in Swedish adolescents at age 17 age 15. Acta Paediatr 2000;89:1162–8.10.1111/j.1651-2227.2000.tb00729.xSuche in Google Scholar

15. Tilghman SM, Belayew A. Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci USA 1982;79:5254–7.10.1073/pnas.79.17.5254Suche in Google Scholar PubMed PubMed Central

16. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997;82:2056–61.Suche in Google Scholar

17. Huang Y, Eapen E, Steele S, Grey V. Establishment of reference intervals for bone markers in children and adolescents. Clin Biochem 2011;44:771–8.10.1016/j.clinbiochem.2011.04.008Suche in Google Scholar PubMed

18. Kulasingam V, Jung BP, Blasutig IM, Baradaran S, Chan MK, Aytekin M, et al. Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer–a CALIPER pilot study. Clin Biochem 2010;43:1045–50.10.1016/j.clinbiochem.2010.05.008Suche in Google Scholar PubMed

19. Djemli A, Van VG, Belgoudi J, Lambert M, Delvin EE. Reference intervals for free thyroxine, total triiodothyronine, thyrotropin and thyroglobulin for Quebec newborns, children and teenagers. Clin Biochem 2004;37:328–30.10.1016/j.clinbiochem.2003.12.006Suche in Google Scholar PubMed

20. Owen WE, Bunker AM, Straseski JA. Pediatric reference intervals for thyroglobulin using the Beckman Coulter Access 2 immunoassay. Clin Chim Acta 2014;435:40–1.10.1016/j.cca.2014.04.013Suche in Google Scholar PubMed

21. Pezzino V, Filetti S, Belfiore A, Proto S, Donzelli G, Vigneri R. Serum thyroglobulin levels in the newborn. J Clin Endocrinol Metab 1981;52:364–6.10.1210/jcem-52-2-364Suche in Google Scholar PubMed

22. Soldin OP, Hoffman EG, Waring MA, Soldin SJ. Pediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000. Clin Chim Acta 2005;355:205–10.10.1016/j.cccn.2005.01.006Suche in Google Scholar PubMed PubMed Central


Supplemental Material:

The online version of this article (DOI: 10.1515/cclm-2015-0558) offers supplementary material, available to authorized users.


Received: 2015-6-12
Accepted: 2015-8-27
Published Online: 2015-10-10
Published in Print: 2016-4-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Macroprolactin: searching for a needle in a haystack?
  4. Review
  5. Laboratory medicine in the new healthcare environment
  6. Opinion Paper
  7. Developing GRADE outcome-based recommendations about diagnostic tests: a key role in laboratory medicine policies
  8. EFLM Survey
  9. Accreditation process in European countries – an EFLM survey
  10. Genetics and Molecular Diagnostics
  11. HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran Vía [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364_366dupGTG]: description of five new hemoglobinopathies
  12. General Clinical Chemistry and Laboratory Medicine
  13. A candidate reference method using ICP-MS for sweat chloride quantification
  14. Quantification of hemoglobin A1c by off-line HPLC separation and liquid chromatography-tandem mass spectrometry: a modification of the IFCC reference measurement procedure
  15. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods – a prospective multinational trial
  16. Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting
  17. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms
  18. A possible cause of the variable detectability of macroprolactin by different immunoassay systems
  19. A multicenter comparison of whole blood vitamin B6 assays
  20. Analytical and clinical performance of the new Fujirebio 25-OH vitamin D assay, a comparison with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and three other automated assays
  21. Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry
  22. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers
  23. Reference Values and Biological Variations
  24. Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children
  25. Development of reference intervals for serum alkaline phosphatase among adults in Southern China traced to the new IFCC reference measurement procedure
  26. Birth season predicts the values of red blood cell distribution width (RDW) in adulthood
  27. Cardiovascular Diseases
  28. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
  29. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease
  30. Infectious Diseases
  31. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
  32. Letters to the Editor
  33. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia
  34. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a reply
  35. STORE (Sample Tracking: Organization, Refrigeration and Expansion): a project in a clinical laboratory perspective
  36. Control materials for immunochromatographic strip used for α-thalassemia screening
  37. Comparison of a 10- vs. 15-min centrifugation time for chemical and immunochemical assays and impact on turnaround time in a hospital laboratory
  38. Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport
  39. The efficacy of an internet-based e-learning system using the CellaVision Competency Software for continuing professional development
  40. Clinical examinations after the Fukushima disaster: a case report of Soma General Hospital
  41. Non-fasting plasma glucose concentration in blood donors
  42. Analytical evaluation of a second generation assay for chromogranin A; a dual-site study
  43. UBE3A, c.1347_1348delGA: a mutation in question
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0558/pdf
Button zum nach oben scrollen